Ads
related to: copd latest treatment news articles
Search results
Results from the WOW.Com Content Network
A new COPD drug, developed by Verona Pharma, was approved by the FDA Wednesday. The drug, ensifentrine, is the first new type of maintenance treatment for COPD in over a decade.
The U.S. health regulator's assent on Wednesday for the therapy, branded as Ohtuvayre, gives patients with chronic obstructive pulmonary disease (COPD) a new inhalable, non-steroid treatment.
GLP-1 and SGLT-2 drugs may be the best treatments for people with type 2 diabetes and COPD. Image credit: Visual Vic/Getty Images. This article originally appeared on Medical News Today
COPD is defined as a forced expiratory volume in 1 second divided by the forced vital capacity (FEV1/FVC) that is less than 0.7 (or 70%). [8] The residual volume, the volume of air left in the lungs following full expiration, is often increased in COPD, as is the total lung capacity, while the vital capacity remains relatively normal.
[1] [2] They have organized the annual awareness day, World COPD Day, every November since 2002. [ 3 ] This organization issues recommendations for the treatment of chronic obstructive pulmonary disease and related medical conditions.
The 2023 theme for World COPD Day is “Breathing is Life - Act Earlier”. This theme underscores the importance of early lung health, early diagnosis, and prompt interventions. COPD can start early in life, affecting young individuals, and identifying precursor conditions allows for timely treatment. [10] [11]
Ads
related to: copd latest treatment news articles